UF Tissue Chip Experiment to Study Age-Related Muscle Loss Aboard International Space Station
An out-of-this-world mission may help University of Florida researchers understand why adults lose muscle strength as they age. Tiny muscle cells contained on tissue chips are part of an innovative experiment bound for the International Space Station.
UF Startup Helping Veterinarians Take Animal Vital Signs Brings Its Product to the Zoo
Vik Ramprakash, founder of UF startup Structured Monitoring Products (SMP), is making the process of taking vital signs easier and safer. The company’s VetGuardian monitor remotely gathers vital signs, including temperature, pulse and respiration of sick, injured or post-operative animals.
AbFero to Receive € 2M Eurostars Funding for Parkinson’s Disease Therapy
AbFero Ltd., a subsidiary of UF startup AbFero Pharmaceuticals, Inc., a privately-held clinical-stage pharmaceutical company dedicated to treating diseases of iron overload, announced the funding of approximately € 2M from EUREKA Eurostars for the development of iron-chelating compounds including their lead agent, SP-420, as a disease-modifying therapy for Parkinson's disease.
White Strawberry One of Two New UF/IFAS Varieties Ready for Harvest Season
Just in time for the west-central Florida strawberry harvesting season, which runs from now until the end of March, UF/IFAS is releasing not one, but two new varieties – and the white strawberry is one of them. The other: another cultivar that UF/IFAS’ primary breeder says tastes oh-so-good.
Pets, Perseverance, and Manufacturing Facility Bring Biotech Success
Patricia Lawman, co-founder and CEO of the biotech firm Morphogenesis, a UF startup and UF Innovate | Sid Martin Biotech graduate company, has always been amazed at how our bodies can defeat illnesses and usually do it better than drugs.
Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.
UF startup Sun BioPharma, Inc., a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has announced the change of its corporate name to Panbela Therapeutics, Inc. effective December 2, 2020.
TearClear Announces Successful Completion of Pre-IND Meeting With the FDA for a Preservative Free Multi-Dose Delivery of Latanoprost for the Treatment of Glaucoma
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, an emerging ophthalmic pharmaceutical company, announced successful completion of pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development plan for the preservative free multi-dose delivery of a proprietary Latanoprost formulation, including the clinical study design for the registration study.
UF Researcher Finds a Way to Mitigate Acute Respiratory Distress Syndrome (ARDS), a Complication of Coronavirus Infection
Why would a doctor specializing in gastrointestinal disorders be interested in therapy for COVID-19, a primarily pulmonary disease? The answer lies in a seemingly convoluted link between the gastrointestinal tract and the lungs: water.
University of Florida Citrus Faculty Highly Sought After as Research Partners in Fight Against Greening
University of Florida citrus researchers continue to be sought out as partners in ground-breaking research projects to fight Huanglongbing, also known as citrus greening disease.
Zare’s $1.2 Million Award Brings Machine Learning to Plant Root Science
A team of researchers from ECE Florida and IFAS has received a $1.2M grant from the United States Department of Agriculture (USDA) that combines machine learning, hyperspectral cameras, and minirhizotron tubes to study root systems of plants over time.
